Oryzon Genomics S.A. (BME:ORY)
2.620
+0.040 (1.55%)
Aug 13, 2025, 5:35 PM CET
Paramount Global Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 31.11 | 5.62 | 12.26 | 21.32 | 28.72 | 39.6 | Upgrade |
Cash & Short-Term Investments | 31.11 | 5.62 | 12.26 | 21.32 | 28.72 | 39.6 | Upgrade |
Cash Growth | 208.78% | -54.16% | -42.50% | -25.79% | -27.47% | 12.35% | Upgrade |
Other Receivables | 2.98 | 3.11 | 2.01 | 3.84 | 3.78 | 2.46 | Upgrade |
Receivables | 2.98 | 3.11 | 2.01 | 3.84 | 3.78 | 2.46 | Upgrade |
Inventory | 0.01 | 0 | 0.01 | 0.01 | 0.1 | 0.32 | Upgrade |
Other Current Assets | 0.04 | 0.02 | 0 | - | - | 0 | Upgrade |
Total Current Assets | 34.14 | 8.75 | 14.28 | 25.16 | 32.61 | 42.38 | Upgrade |
Property, Plant & Equipment | 0.31 | 0.36 | 0.48 | 0.61 | 0.68 | 0.64 | Upgrade |
Long-Term Investments | - | - | - | - | - | 0.04 | Upgrade |
Other Intangible Assets | 0.26 | 0.22 | 0.38 | 0.52 | 0.63 | 0.21 | Upgrade |
Long-Term Deferred Tax Assets | 2.42 | 2.39 | 2.22 | 2.05 | 1.81 | 1.8 | Upgrade |
Long-Term Deferred Charges | 101.09 | 96.87 | 89.51 | 75.32 | 59.62 | 49.01 | Upgrade |
Other Long-Term Assets | 0.13 | 0.13 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade |
Total Assets | 138.35 | 108.72 | 106.9 | 103.7 | 95.38 | 94.11 | Upgrade |
Accounts Payable | 2.1 | 2.13 | 3.41 | 5.06 | 2.91 | 2 | Upgrade |
Accrued Expenses | 1.11 | 0.58 | 0.6 | 0.54 | 1.24 | 0.62 | Upgrade |
Short-Term Debt | - | - | - | - | - | 0.14 | Upgrade |
Current Portion of Long-Term Debt | 9.4 | 8.74 | 11.92 | 12.17 | 4.17 | 4.71 | Upgrade |
Current Portion of Leases | 0.02 | 0.02 | 0.02 | 0.02 | - | - | Upgrade |
Other Current Liabilities | 0.36 | 0.27 | 0.46 | 0.93 | 0.35 | 0.22 | Upgrade |
Total Current Liabilities | 13.01 | 11.74 | 16.41 | 18.73 | 8.67 | 7.69 | Upgrade |
Long-Term Debt | 8.67 | 7.42 | 6.28 | 10.27 | 13.35 | 8.68 | Upgrade |
Long-Term Leases | 0.02 | 0.03 | 0.06 | 0.08 | - | - | Upgrade |
Long-Term Deferred Tax Liabilities | 2.42 | 2.39 | 2.22 | 2.05 | 1.81 | 1.8 | Upgrade |
Other Long-Term Liabilities | - | - | 0.15 | - | - | - | Upgrade |
Total Liabilities | 24.13 | 21.67 | 25.13 | 31.13 | 24.12 | 18.18 | Upgrade |
Common Stock | 3.93 | 3.29 | 3.06 | 2.78 | 2.65 | 2.65 | Upgrade |
Additional Paid-In Capital | 130.08 | 100.71 | 92.38 | 79.69 | 73.96 | 73.96 | Upgrade |
Retained Earnings | -20.88 | -19.29 | -15.62 | -12.27 | -8.04 | -3.35 | Upgrade |
Treasury Stock | -2.03 | -2.03 | -0.55 | -0.62 | -0.69 | -0.69 | Upgrade |
Comprehensive Income & Other | 3.13 | 4.36 | 2.51 | 3 | 3.38 | 3.36 | Upgrade |
Shareholders' Equity | 114.22 | 87.04 | 81.77 | 72.57 | 71.26 | 75.93 | Upgrade |
Total Liabilities & Equity | 138.35 | 108.72 | 106.9 | 103.7 | 95.38 | 94.11 | Upgrade |
Total Debt | 18.12 | 16.21 | 18.27 | 22.54 | 17.52 | 13.53 | Upgrade |
Net Cash (Debt) | 12.99 | -10.59 | -6.02 | -1.22 | 11.2 | 26.07 | Upgrade |
Net Cash Growth | - | - | - | - | -57.02% | 18.46% | Upgrade |
Net Cash Per Share | 0.17 | -0.16 | -0.10 | -0.02 | 0.21 | 0.49 | Upgrade |
Filing Date Shares Outstanding | 77.51 | 64.75 | 60.88 | 55.29 | 52.76 | 52.76 | Upgrade |
Total Common Shares Outstanding | 77.51 | 64.75 | 60.88 | 55.29 | 52.76 | 52.76 | Upgrade |
Working Capital | 21.13 | -2.99 | -2.14 | 6.43 | 23.93 | 34.68 | Upgrade |
Book Value Per Share | 1.47 | 1.34 | 1.34 | 1.31 | 1.35 | 1.44 | Upgrade |
Tangible Book Value | 113.96 | 86.82 | 81.39 | 72.05 | 70.63 | 75.72 | Upgrade |
Tangible Book Value Per Share | 1.47 | 1.34 | 1.34 | 1.30 | 1.34 | 1.44 | Upgrade |
Machinery | 1.62 | 1.62 | 1.62 | 1.64 | 1.6 | 1.56 | Upgrade |
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.